Cargando…
Marketing the COVID-19 vaccine and the implications for public health
COVID-19 vaccines are new brands of consumer health technology being introduced to the market. Considering consumer behaviour approaches in this time of crisis, the risk of vaccine hesitancy, the call for more transparency and effective messaging to gain trust, and equitable distribution of this vac...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275479/ https://www.ncbi.nlm.nih.gov/pubmed/34281742 http://dx.doi.org/10.1016/j.vaccine.2021.07.015 |
_version_ | 1783721723236974592 |
---|---|
author | Mogaji, Emmanuel |
author_facet | Mogaji, Emmanuel |
author_sort | Mogaji, Emmanuel |
collection | PubMed |
description | COVID-19 vaccines are new brands of consumer health technology being introduced to the market. Considering consumer behaviour approaches in this time of crisis, the risk of vaccine hesitancy, the call for more transparency and effective messaging to gain trust, and equitable distribution of this vaccine, this is unexplored theoretical terrain. This commentary takes a multidisciplinary approach to understand and theoretically explore the marketing, distribution, and acceptance of the COVID-19 vaccine. The paper integrates marketing principles, including advertisement and branding of consumer health technology with supply chain management, public affairs, and public health. A theoretical framework was presented to illustrate this relationship and key areas of concerns. The practical implications relevant to equity, ethics, education, employment, and the economic impact was presented. |
format | Online Article Text |
id | pubmed-8275479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82754792021-07-14 Marketing the COVID-19 vaccine and the implications for public health Mogaji, Emmanuel Vaccine Commentary COVID-19 vaccines are new brands of consumer health technology being introduced to the market. Considering consumer behaviour approaches in this time of crisis, the risk of vaccine hesitancy, the call for more transparency and effective messaging to gain trust, and equitable distribution of this vaccine, this is unexplored theoretical terrain. This commentary takes a multidisciplinary approach to understand and theoretically explore the marketing, distribution, and acceptance of the COVID-19 vaccine. The paper integrates marketing principles, including advertisement and branding of consumer health technology with supply chain management, public affairs, and public health. A theoretical framework was presented to illustrate this relationship and key areas of concerns. The practical implications relevant to equity, ethics, education, employment, and the economic impact was presented. Elsevier Ltd. 2021-08-09 2021-07-13 /pmc/articles/PMC8275479/ /pubmed/34281742 http://dx.doi.org/10.1016/j.vaccine.2021.07.015 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Mogaji, Emmanuel Marketing the COVID-19 vaccine and the implications for public health |
title | Marketing the COVID-19 vaccine and the implications for public health |
title_full | Marketing the COVID-19 vaccine and the implications for public health |
title_fullStr | Marketing the COVID-19 vaccine and the implications for public health |
title_full_unstemmed | Marketing the COVID-19 vaccine and the implications for public health |
title_short | Marketing the COVID-19 vaccine and the implications for public health |
title_sort | marketing the covid-19 vaccine and the implications for public health |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275479/ https://www.ncbi.nlm.nih.gov/pubmed/34281742 http://dx.doi.org/10.1016/j.vaccine.2021.07.015 |
work_keys_str_mv | AT mogajiemmanuel marketingthecovid19vaccineandtheimplicationsforpublichealth |